NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr | ₹811,693 Cr |
What is the latest Consolidated Net Profit of NGL FINECHEM ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹41 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹50 Cr |
| Mar2022 | ₹57 Cr |
| Mar2021 | ₹811,693 Cr |
How is Consolidated Net Profit of NGL FINECHEM Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹41 Cr | 101.67 | |
| Mar2024 | ₹20 Cr | -59.05 | |
| Mar2023 | ₹50 Cr | -11.91 | |
| Mar2022 | ₹57 Cr | -99.99 | |
| Mar2021 | ₹811,693 Cr | - | |
Compare Consolidated Net Profit of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹933.2 Cr | 2.4% | 17.7% | -7.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 2.4% |
17.7% |
-7.4% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses